Cas:9000-16-2 dammar resin manufacturer & supplier

We serve Chemical Name:dammar resin CAS:9000-16-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

dammar resin

Chemical Name:dammar resin
CAS.NO:9000-16-2
Synonyms:dammar resin
Molecular Formula:N/A
Molecular Weight:N/A
HS Code:

Physical and Chemical Properties:
Melting point:~120°
Boiling point:N/A
Density:1.04-1.12
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like dammar resin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,dammar resin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,dammar resin Use and application,dammar resin technical grade,usp/ep/jp grade.


Related News: According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017). dammar resin manufacturer Bulk bulk medicines: overcapacity, low prices, future capacity and output will be reduced, and it is possible to transfer foreign production. dammar resin supplier Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK. dammar resin vendor The European Medicines Agency did not say how many shots were affected, but Reuters has reported it involves millions of doses, making it harder for J&J to meet a target of delivering 55 million to Europe by end of June. dammar resin factory No amount of unmet need can take the place of sufficient evidence, said Johns Hopkins public health professor Dr. Caleb Alexander, a member of the FDA advisory panel.